Annual EBIT
-$12.89 M
+$10.08 M+43.87%
December 31, 2023
Summary
- As of February 7, 2025, SLRX annual earnings before interest & taxes is -$12.89 million, with the most recent change of +$10.08 million (+43.87%) on December 31, 2023.
- During the last 3 years, SLRX annual EBIT has fallen by -$5.28 million (-69.43%).
- SLRX annual EBIT is now -69.43% below its all-time high of -$7.61 million, reached on December 31, 2020.
Performance
SLRX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$1.01 M
+$461.00 K+31.41%
September 30, 2024
Summary
- As of February 7, 2025, SLRX quarterly earnings before interest & taxes is -$1.01 million, with the most recent change of +$461.00 thousand (+31.41%) on September 30, 2024.
- Over the past year, SLRX quarterly EBIT has increased by +$765.10 thousand (+43.19%).
- SLRX quarterly EBIT is now -10.35% below its all-time high of -$912.10 thousand, reached on June 30, 2019.
Performance
SLRX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$5.22 M
+$1.53 M+22.63%
September 30, 2024
Summary
- As of February 7, 2025, SLRX TTM earnings before interest & taxes is -$5.22 million, with the most recent change of +$1.53 million (+22.63%) on September 30, 2024.
- Over the past year, SLRX TTM EBIT has increased by +$4.03 million (+43.58%).
- SLRX TTM EBIT is now -137.94% below its all-time high of -$2.19 million, reached on June 30, 2014.
Performance
SLRX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
SLRX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +43.9% | +43.2% | +43.6% |
| 3 y3 years | -69.4% | +74.7% | +75.7% |
| 5 y5 years | +41.6% | +74.7% | +75.7% |
SLRX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -0.6% | +43.9% | -3.7% | +84.5% | at high | +77.3% |
| 5 y | 5-year | -69.4% | +43.9% | -3.7% | +84.5% | at high | +77.3% |
| alltime | all time | -69.4% | +67.7% | -10.3% | +91.2% | -137.9% | +86.9% |
Salarius Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.01 M(-31.4%) | -$5.22 M(-22.6%) |
| Jun 2024 | - | -$1.47 M(-17.2%) | -$6.74 M(-27.1%) |
| Mar 2024 | - | -$1.77 M(+82.5%) | -$9.25 M(-28.3%) |
| Dec 2023 | -$12.89 M(-43.9%) | -$970.70 K(-61.7%) | -$12.89 M(-29.9%) |
| Sep 2023 | - | -$2.53 M(-36.2%) | -$18.40 M(-14.4%) |
| Jun 2023 | - | -$3.97 M(-26.7%) | -$21.49 M(-3.5%) |
| Mar 2023 | - | -$5.42 M(-16.3%) | -$22.28 M(-3.0%) |
| Dec 2022 | -$22.98 M(+79.3%) | -$6.48 M(+15.2%) | -$22.98 M(+11.3%) |
| Sep 2022 | - | -$5.62 M(+18.2%) | -$20.64 M(+10.0%) |
| Jun 2022 | - | -$4.76 M(-22.2%) | -$18.77 M(+9.6%) |
| Mar 2022 | - | -$6.12 M(+47.6%) | -$17.13 M(+33.7%) |
| Dec 2021 | -$12.81 M(+68.4%) | -$4.14 M(+10.6%) | -$12.81 M(+22.9%) |
| Sep 2021 | - | -$3.75 M(+20.2%) | -$10.43 M(+23.6%) |
| Jun 2021 | - | -$3.12 M(+72.7%) | -$8.44 M(+19.8%) |
| Mar 2021 | - | -$1.80 M(+2.5%) | -$7.05 M(-7.4%) |
| Dec 2020 | -$7.61 M(-7.9%) | -$1.76 M(+0.1%) | -$7.61 M(-3.8%) |
| Sep 2020 | - | -$1.76 M(+2.1%) | -$7.91 M(-20.2%) |
| Jun 2020 | - | -$1.72 M(-27.3%) | -$9.91 M(+8.9%) |
| Mar 2020 | - | -$2.37 M(+15.1%) | -$9.10 M(+1.4%) |
| Dec 2019 | -$8.26 M | -$2.06 M(-45.3%) | -$8.97 M(+0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$3.76 M(+312.3%) | -$8.94 M(+13.9%) |
| Jun 2019 | - | -$912.10 K(-59.3%) | -$7.84 M(-51.1%) |
| Mar 2019 | - | -$2.24 M(+11.0%) | -$16.04 M(-27.4%) |
| Dec 2018 | -$22.07 M(-36.4%) | -$2.02 M(-24.2%) | -$22.07 M(-21.6%) |
| Sep 2018 | - | -$2.67 M(-70.7%) | -$28.15 M(-19.3%) |
| Jun 2018 | - | -$9.10 M(+9.9%) | -$34.89 M(+0.7%) |
| Mar 2018 | - | -$8.28 M(+2.3%) | -$34.66 M(-0.2%) |
| Dec 2017 | -$34.73 M(-12.9%) | -$8.09 M(-14.0%) | -$34.73 M(+0.3%) |
| Sep 2017 | - | -$9.41 M(+6.0%) | -$34.62 M(-3.7%) |
| Jun 2017 | - | -$8.88 M(+6.4%) | -$35.94 M(-6.7%) |
| Mar 2017 | - | -$8.35 M(+4.5%) | -$38.54 M(-3.4%) |
| Dec 2016 | -$39.89 M(+36.5%) | -$7.98 M(-25.6%) | -$39.89 M(+0.1%) |
| Sep 2016 | - | -$10.74 M(-6.4%) | -$39.83 M(+6.9%) |
| Jun 2016 | - | -$11.47 M(+18.3%) | -$37.26 M(+13.3%) |
| Mar 2016 | - | -$9.70 M(+22.3%) | -$32.89 M(+12.6%) |
| Dec 2015 | -$29.21 M | -$7.93 M(-2.9%) | -$29.21 M(+37.3%) |
| Sep 2015 | - | -$8.17 M(+15.1%) | -$21.28 M(+40.9%) |
| Jun 2015 | - | -$7.09 M(+17.8%) | -$15.11 M(+48.0%) |
| Mar 2015 | - | -$6.02 M(+202.1%) | -$10.21 M(+143.9%) |
| Sep 2014 | - | -$1.99 M(-9.1%) | -$4.19 M(+90.9%) |
| Jun 2014 | - | -$2.19 M | -$2.19 M |
FAQ
- What is Salarius Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals annual EBIT year-on-year change?
- What is Salarius Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals quarterly EBIT year-on-year change?
- What is Salarius Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals TTM EBIT year-on-year change?
What is Salarius Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of SLRX is -$12.89 M
What is the all time high annual EBIT for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high annual earnings before interest & taxes is -$7.61 M
What is Salarius Pharmaceuticals annual EBIT year-on-year change?
Over the past year, SLRX annual earnings before interest & taxes has changed by +$10.08 M (+43.87%)
What is Salarius Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of SLRX is -$1.01 M
What is the all time high quarterly EBIT for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high quarterly earnings before interest & taxes is -$912.10 K
What is Salarius Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, SLRX quarterly earnings before interest & taxes has changed by +$765.10 K (+43.19%)
What is Salarius Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of SLRX is -$5.22 M
What is the all time high TTM EBIT for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high TTM earnings before interest & taxes is -$2.19 M
What is Salarius Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, SLRX TTM earnings before interest & taxes has changed by +$4.03 M (+43.58%)